Cervical myelography with iohexol

An open study with iohexol (Omnipaque) in cervical myelography has been performed in 20 patients to evaluate the properties and neurotoxicity of this new water soluble contrast medium. The image quality was good (30%) or excellent (70%) in all cases. The frequency of headache was 25%. No EEG changes...

Full description

Saved in:
Bibliographic Details
Published in:Neuroradiology 1984-01, Vol.26 (2), p.123-129
Main Authors: NAKSTAD, P, AASERUD, O, HELGETVEIT, A, NYBERG-HANSEN, R, GANES, T, BACH-GANSMO, T
Format: Article
Language:English
Subjects:
Adult
Aged
Biological and medical sciences
Contrast Media
Contrast media. Radiopharmaceuticals
Drug Evaluation
Electroencephalography
Female
Headache - chemically induced
Humans
Intervertebral Disc Displacement - diagnostic imaging
Iodobenzoates
Iohexol
Male
Medical sciences
Middle Aged
Myelography - methods
Nausea - chemically induced
Pharmacology. Drug treatments
Spinal Cord Diseases - diagnostic imaging
Spinal Stenosis - diagnostic imaging
Triiodobenzoic Acids - adverse effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An open study with iohexol (Omnipaque) in cervical myelography has been performed in 20 patients to evaluate the properties and neurotoxicity of this new water soluble contrast medium. The image quality was good (30%) or excellent (70%) in all cases. The frequency of headache was 25%. No EEG changes were severe and the total frequency was 20%. We conclude that this study supports other reports of iohexol having a low neurotoxicity and is well suited for intrathecal use.
ISSN:0028-3940
1432-1920
DOI:10.1007/BF00339860